The Trump administration is aiming to lower drug prices by eliminating kickbacks to middlemen, like pharmacy benefit managers (PBMs), and increasing drug importation in three new executive orders...
Two-thirds of US adults reported that prescription drug prices have increased either “a little” or “a lot” since 2017, the first year of the Trump administration, according to a...
CMS announced last week that they developed a new billing code for providers and laboratories to test patients for the coronavirus, or SARS-CoV-2.
For more coronavirus updates, visit our...
Weakness in the oversight of the 340B Drug Discount Program allowed some hospitals to get discounted drugs they were ineligible for, a Government Accountability Office analysis found.
Hospitals,...
A new study finds that leveraging physician ties can promote targeted adoption of high-value therapies.
As part of the longitudinal study published in JAMA, researchers constructed physician networks...
In October 2018, the Trump administration proposed an international reference pricing model to reduce the federal government's spending on prescription drugs.
The International Pricing Index (IPI)...
